Ninepoint Partners LP Merck & Co., Inc. Transaction History

Ninepoint Partners LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$123.8 - $132.96 $49,396 - $53,051	-399 Reduced 6.97%	5,327 $659,000
Q1 2024 May 13, 2024	BUY	$113.24 - $131.95 $648,412 - $755,545	5,726 New	5,726 $755,000
Q1 2023 May 04, 2023	BUY	$102.94 - $114.86 $591,699 - $660,215	5,748 New	5,748 $611,000
Q1 2020 Apr 28, 2020	SELL	$63.36 - $87.82 $326,620 - $452,712	-5,155 Closed	0 $0
Q4 2019 Jan 24, 2020	BUY	$77.58 - $87.54 $399,924 - $451,268	5,155 New	5,155 $469,000
Q3 2019 Oct 30, 2019	SELL	$76.08 - $82.93 $460,664 - $502,141	-6,055 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$69.84 - $81.59 $422,881 - $494,027	6,055 New	6,055 $508,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Ninepoint Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ninepoint Partners LP with notifications on news.